3-nitropropionic acid has been researched along with rifampin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhat, P; Senthilkumar, P; Sriram, D; Srividya, M; Vyas, DR; Yogeeswari, P | 1 |
Banerjee, D; Bhat, P; Sriram, D; Srividya, M; Thomas, A; Yogeeswari, P | 1 |
Aree, T; Ganihigama, DU; Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Sangher, S; Sureram, S | 1 |
Baranyai, Z; Bősze, S; Janďourek, O; Krátký, M; Novotná, E; Stolaříková, J; Vinšová, J | 1 |
4 other study(ies) available for 3-nitropropionic acid and rifampin
Article | Year |
---|---|
5-Nitro-2-furoic acid hydrazones: design, synthesis and in vitro antimycobacterial evaluation against log and starved phase cultures.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Catalytic Domain; Chlorocebus aethiops; Computer Simulation; Drug Design; Enzyme Inhibitors; Furans; Hydrazines; Hydrazones; Isocitrate Lyase; Microbial Sensitivity Tests; Mycobacterium; Vero Cells | 2010 |
Novel isatinyl thiosemicarbazones derivatives as potential molecule to combat HIV-TB co-infection.
Topics: Anti-Bacterial Agents; Anti-HIV Agents; Cell Line; HIV; HIV Infections; HIV Reverse Transcriptase; Isocitrate Lyase; Models, Molecular; Molecular Conformation; Mycobacterium tuberculosis; Thiosemicarbazones; Tuberculosis | 2011 |
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Quinolines; Structure-Activity Relationship | 2015 |
Phenolic N-monosubstituted carbamates: Antitubercular and toxicity evaluation of multi-targeting compounds.
Topics: Antitubercular Agents; Carbamates; Hep G2 Cells; Humans; Isocitrate Lyase; Mycobacterium tuberculosis; Phenols; Salicylanilides; Tuberculosis | 2019 |